Contact
Please use this form to send email to PR contact of this press release:
NGMEDICAL Announces Completion of Patient Enrollment in the one- and two-Level MOVE®-C Clinical Trial
TO:
Peter Weiland
NGMedical GmbH
+49 6873999970